Physician profile
Gregory T Sutton
NPI 1144699869
$1,528.72
in general payments reported to CMS, 2019-2025
10 companies · $37.31 in 2025
The $37.31 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,065 · 2021: $11.01 · 2022: $80.04 · 2023: $134 · 2024: $202 · 2025: $37.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $372.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Orthopedics LLC | $1,064.74 | 2020 | |
| Kerecis Limited | $101.66 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Organogenesis INC. | $95.73 | 2021-2025 | Puraply Antimicrobial, Puraply, Puraply Wound Matrix |
| Integra Lifesciences Corporation | $80.04 | 2022 | |
| Sanara Medtech INC. | $67.73 | 2024 | Celleraterx |
| Paragon 28, INC. | $46.33 | 2023 | Portfolio |
| Sun Pharmaceutical Industries INC. | $21.97 | 2025 | |
| Smith+Nephew, INC. | $19.15 | 2024 | Pico 14, Renasys Go V2 Home, Renasys Touch |
| Nevro Corp. | $18.16 | 2023 | Senza |
| Depuy Synthes Sales INC. | $13.21 | 2024 | Na, Motoband, Fibulink |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Sutton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.